Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep744 | Endocrine Disruptors | ECE2017

Systematic screening for environmental and behavioral determinants identifies factors detrimental to skeletal health

Oei Ling , Wu Joy , Oei Edwin , Rivadeneira Fernando , Uitterlinden Andre , Ioannidis John , Snyder Michael , Patel Chirag

Background: An increasing amount of biomedical data is becoming available, and methods are needed to tackle these “big data”.Methods: We performed a systematic evaluation of 138 environmental and behavioral factors in relation to bone mineral density (BMD) in the National Health and Nutrition Examination Survey (NHANES). Dual energy X-ray absorptiometry (DXA) scans were available for total body, head, pelvis and lumbar spine for 27,259 particip...

ea0020p357 | Diabetes and Cardiovascular | ECE2009

Pharmacokinetics of the dipeptidyl peptidase-4 inhibitor saxagliptin in subjects with renal impairment

Boulton David , Tang Angela , Patel Chirag , Li Li , Xu Xiaohui , Frevert Ernst , Kornhauser David

Background/aims: Saxagliptin is a potent, selective dipeptidyl peptidase-4 (DPP-4) inhibitor, specifically designed for extended inhibition of the DPP-4 enzyme. Saxagliptin is cleared by both metabolism and renal excretion. The aims of this study were to determine the effect of renal impairment (RI) and haemodialysis (HD) on the pharmacokinetics of saxagliptin.Methods: This open-label, parallel-group study was conducted in subjects with normal renal func...